Study of Ofatumumab and ESHAP for the Treatment of Hodgkin's Lymphoma
Clinical trial NCT01195766 · COMPLETED
Trial details
- NCT number
- NCT01195766
- Sponsor
- Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2013-09-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.